Welcome to our dedicated page for MindWalk Holdings SEC filings (Ticker: HYFT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MindWalk Holdings Corp. (NASDAQ: HYFT) files as a foreign private issuer in the United States and provides its regulatory disclosures primarily through annual reports on Form 20-F and current reports on Form 6-K. These SEC filings offer detailed information on the company’s Bio-Native AI business, financial position and capital markets activities.
On this page, users can access MindWalk’s Form 20-F, which includes audited financial statements prepared under IFRS, risk factor discussions and descriptions of its HYFT and LensAI platform. The company’s Form 6-K filings cover a range of topics, including quarterly earnings releases, pro forma condensed consolidated financial information, statements of executive compensation, reports of voting results and press releases that are incorporated by reference into its registration statements.
MindWalk has also filed 6-K reports describing a Sales Agreement with JonesTrading Institutional Services LLC for an at-the-market equity offering facility under an effective Form F-3 shelf registration statement. Other filings reference a share repurchase program authorized by the board of directors and the classification of certain operations as discontinued following the sale of its Netherlands business.
Through this SEC filings page, Stock Titan surfaces real-time updates from the EDGAR system and pairs them with AI-powered summaries that help explain the contents of lengthy documents. Users can quickly locate MindWalk’s annual report (Form 20-F), interim updates furnished on Form 6-K, and information incorporated into Forms F-3 and S-8. Filings related to equity offerings, executive compensation and program-level financial reporting can be reviewed with AI-generated highlights that clarify key points without replacing the underlying source documents.
MindWalk Holdings Corp. furnished a Form 6-K that includes Exhibit 99.1, a Revised Statement of Executive Compensation dated November 6, 2025.
The company states that Exhibit 99.1 is incorporated by reference into its existing registration statements on Form S-8 and Form F-3. The report was signed by Chief Executive Officer Jennifer Bath.
MindWalk Holdings Corp. filed a Form S-8 registering 5,620,254 common shares issuable under the ImmunoPrecise Antibodies Ltd. 2025 Stock Incentive Plan. The shares may be issued through equity awards, including options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, or other stock-based awards.
The company is a non-accelerated filer and an emerging growth company. Standard indemnification provisions for directors and officers under the British Columbia Business Corporations Act and the company’s articles are described, along with related insurance coverage.